IRICoR congratulates Drs. Guy Sauvageau and Anne Marinier, along with their respective teams for obtaining Health Canada’s approval to start clinical trials with the UM171 compound.
For more information, please read the news on IRIC’s Website : Health Canada allows clinical trials for the molecule UM171
